Topic:

Chutes and Ladders

Latest Headlines

Latest Headlines

Andrew Allen tapped to lead cancer immunotherapy developer Gritstone

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

UPDATED: Biogen axes 800-plus jobs to keep Tecfidera sales engine running

Biogen has been traveling a rough road lately, with slower-than-expected sales for its hot-selling MS med Tecfidera prompting the company to lower its forecast earlier this year. And now, it's rolling out a restructuring to help bolster the drug.

Struggling Daiichi plots another 1,000-plus job cuts in U.S.

Japan-based drugmaker Daiichi Sankyo will cut up to 1,200 jobs in the U.S., about half its workforce in its stateside subsidiary, Nikkei reports. The announcement follows a series of layoffs earlier this year at its Parsippany, NJ, operations.

Merck KGaA taps Stefan Oschmann to lead company's next chapter

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

Allergan plots 117 job cuts in the wake of Kythera buyout

The job-cutting ax has been hovering over Kythera Biopharmaceuticals ever since Allergan agreed to buy the company in April. Now, that ax is getting ready to fall.

Merck KGaA tasks new CEO Oschmann with company turnaround

Merck KGaA has been revamping its top lineup lately, streamlining the executive team for its healthcare business last month after a series of cost-cutting and reorganizational measures. In it latest round of musical chairs, the company has named Stefan Oschmann as its new CEO, charging him with the next chapter in the drugmaker's ongoing comeback story.

Arena CEO Jack Lief steps down as requested by the board

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

Investors cheer as Arena forces out CEO and cofounder

Arena Pharmaceuticals' board of directors is getting its way: CEO Jack Lief is hitting the road.

Habib Dable to lead Bayer's U.S. pharma business

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...

Stephen Ubl planning move from AdvaMed to PhRMA: Reports

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Eric Sagonowsky (email) or...
'